IPP Bureau
Venus Remedies secures marketing approval from Israel, Colombia for two oncology drugs
By IPP Bureau - December 30, 2023
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
Qure solidifies its position as innovation powerhouse with 26 patents
By IPP Bureau - December 30, 2023
Marks remarkable acceleration in innovation using AI technology
Dr. Reddy's Laboratories acquires Preferred A-1 shares of Edity Therapeutics
By IPP Bureau - December 30, 2023
The acquisition is done through cash consideration, by way of conversion of SAFE (Simple Agreement for Future Equity) investment of US$ 2 Million to Preferred A-1 Shares
Karkions Healthcare bags DSCI Excellence Award 2023
By IPP Bureau - December 29, 2023
Karkinos Healthcare has demonstrated exceptional dedication to privacy, setting a commendable example for businesses navigating the complexities of the digital landscape
Akums to empower mothers with Doxylamine + Pyridoxine extended-release tablets for severe morning sickness
By IPP Bureau - December 28, 2023
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
Ecolab recognised by DJSI World and North America Indices
By IPP Bureau - December 28, 2023
Ecolab’s continued leadership position on renowned sustainability indices demonstrates the company’s record of advancing sustainable growth
Innovent Biologics, Xuanzhu collaborate on clinical trial for advanced solid tumors in China
By IPP Bureau - December 28, 2023
Innovent will supply sintilimab for the collaborated clinical trial
Innovent and SanegeneBio collaborate to develop siRNA drug for treatment of hypertension
By IPP Bureau - December 28, 2023
Innovent also obtains an exclusive option to license in the future development, manufacturing and commercialization rights of SGB-3908
Elpiscience and Astellas collaborate for novel bispecific macrophage engager
By IPP Bureau - December 28, 2023
Elpiscience will receive up to US $37 million, including the upfront payment and license option fees
Mandaviya virtually launches 'MedTech Mitra'
By IPP Bureau - December 27, 2023
MedTech Mitra is a platform that will help the young talents of the country by holding their hands and giving them final shape to their research, knowledge and logic
Sonowal and Khandu lay foundation stone for capacity expansion at NEIAFMR
By IPP Bureau - December 27, 2023
NEIAFMR to be developed as the national hub for folk medicine
Apollo Hospitals Enterprise reduces stake in Apollo Home Healthcare
By IPP Bureau - December 27, 2023
AHHL is primarily engaged in nursing care, in home primary care, physiotherapy at home, sample collection, post-operative/post-surgical care
Lupin receives USFDA approval for Loteprednol Etabonate Ophthalmic Suspension, 0.2%
By IPP Bureau - December 27, 2023
Loteprednol Etabonate Ophthalmic Suspension, 0.2%, is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis
Eugia Pharma Specialities receives USFDA final approval for Posaconazole Injection
By IPP Bureau - December 27, 2023
The product is expected to be launched in December 2023
Pigeon Singapore, LyondellBasell collaborate to incorporate bio-circular plastic in nursing bottles
By IPP Bureau - December 26, 2023
The LyondellBasell CirculenRenew polymers are made from renewable feedstocks derived from bio-based wastes
